SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 3,032.06 |
| Enterprise Value ($M) | 3,117.59 |
| Book Value ($M) | 153.71 |
| Book Value / Share | 0.66 |
| Price / Book | 19.73 |
| NCAV ($M) | 79.25 |
| NCAV / Share | 0.34 |
| Price / NCAV | 38.26 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.01 |
| Return on Assets (ROA) | -0.01 |
| Return on Equity (ROE) | -0.02 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.86 |
| Current Ratio | 5.21 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 276.42 |
| Assets | 350.88 |
| Liabilities | 197.17 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 258.21 |
| Operating Income | 24.43 |
| Net Income | -28.24 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 8.80 |
| Cash from Investing | -4.98 |
| Cash from Financing | -38.99 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Nuveen Asset Management, LLC | 2.17 | -2.77 | |
| 13G/A | Tiaa Cref Investment Management Llc | 2.17 | -2.77 | |
| 13G/A | Teachers Advisors, Llc | 2.17 | -2.77 | |
| 13G/A | Perceptive Advisors Llc | 2.80 | -45.94 | |
| 13G | Vanguard Group Inc | 5.71 | ||
| 13G/A | BlackRock Inc. | 7.90 | 18.65 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 300,088 | 2,377,358 | 12.62 | |
| 395,468 | 2,312,505 | 17.10 | |
| 342,031 | 1,822,445 | 18.77 | |
| 366,823 | 2,498,619 | 14.68 | |
| 764,341 | 3,584,087 | 21.33 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ACET – Adicet Bio, Inc. | ACIU – AC Immune SA |
| ACRV – Acrivon Therapeutics, Inc. | AFMD – Affimed N.V. |
| ALIM – Alimera Sciences, Inc. |
Financial data and stock pages provided by
Fintel.io